losartan has been researched along with canrenoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funder, JW; Young, MJ | 1 |
| Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM | 1 |
| Cordaillat, M; Jover, B; Mimran, A; Rugale, C | 1 |
3 other study(ies) available for losartan and canrenoic acid
| Article | Year |
|---|---|
The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
Topics: Aldosterone; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Canrenoic Acid; Cardiomegaly; Collagen; Corticosterone; Epithelium; Fibrosis; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Tetrazoles | 1996 |
Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
Topics: Adrenergic beta-Agonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Canrenoic Acid; Fibrosis; Heart Failure; Isoproterenol; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2005 |
Time-course reduction of renal function in rats on high sodium intake: acute reversal by potassium canrenoate.
Topics: Albuminuria; Animals; Blood Pressure; Canrenoic Acid; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney Diseases; Losartan; Male; Rats; Rats, Sprague-Dawley; Sodium, Dietary | 2008 |